121 related articles for article (PubMed ID: 9131273)
1. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression.
Rha SY; Kim JH; Roh JK; Lee KS; Min JS; Kim BS; Chung HC
Breast Cancer Res Treat; 1997 Apr; 43(2):175-81. PubMed ID: 9131273
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression.
Lee KS; Rha SY; Kim SJ; Kim JH; Roh JK; Kim BS; Chung HC
Clin Exp Metastasis; 1996 Nov; 14(6):512-9. PubMed ID: 8970581
[TBL] [Abstract][Full Text] [Related]
3. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
4. Different expression patterns of MMP-2 and MMP-9 in breast cancer.
Rha SY; Yang WI; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Chung HC
Oncol Rep; 1998; 5(4):875-9. PubMed ID: 9625836
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
6. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
7. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
9. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Azzam HS; Arand G; Lippman ME; Thompson EW
J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
[TBL] [Abstract][Full Text] [Related]
11. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
12. Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer.
Liu SC; Yang SF; Yeh KT; Yeh CM; Chiou HL; Lee CY; Chou MC; Hsieh YS
Clin Chim Acta; 2006 Sep; 371(1-2):92-6. PubMed ID: 16581051
[TBL] [Abstract][Full Text] [Related]
13. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.
Devy L; Noël A; Baramova E; Bajou K; Trentesaux C; Jardillier JC; Foidart JM; Jeannesson P
Biochem Biophys Res Commun; 1997 Sep; 238(3):842-6. PubMed ID: 9325178
[TBL] [Abstract][Full Text] [Related]
14. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
15. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
Hahn-Dantona E; Ramos-DeSimone N; Sipley J; Nagase H; French DL; Quigley JP
Ann N Y Acad Sci; 1999 Jun; 878():372-87. PubMed ID: 10415742
[TBL] [Abstract][Full Text] [Related]
16. Metalloproteinases in tumor progression: the contribution of MMP-9.
Himelstein BP; Canete-Soler R; Bernhard EJ; Dilks DW; Muschel RJ
Invasion Metastasis; 1994-1995; 14(1-6):246-58. PubMed ID: 7657517
[TBL] [Abstract][Full Text] [Related]
17. Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72 kDa gelatinase) by ovine endometrial cells in vitro: different regulation and preferential expression by stromal fibroblasts.
Salamonsen LA; Nagase H; Suzuki R; Woolley DE
J Reprod Fertil; 1993 Jul; 98(2):583-9. PubMed ID: 8410828
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
19. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
